Synthesis and evaluation of biological and antitumor activities of 5,7-dimethyl- oxazolo[5,4-d]pyrimidine-4,6(5H,7H)-dione derivatives as novel inhibitors of FGFR1.
Faqing Ye,Yuewu Wang,Siyun Nian,Yu Wang,Di Chen,Shufang Yu,Sicen Wang
DOI: https://doi.org/10.3109/14756366.2014.1002401
2015-01-01
Journal of Enzyme Inhibition and Medicinal Chemistry
Abstract:A series of 5,7-dimethyl-oxazolo[ 5,4-d]pyrimidine-4,6(5H,7H)-dione derivatives, N5a-5l, was designed, synthesized and evaluated for their FGFR1-inhibition ability as well as cytotoxicity against three cancer cell lines (H460, B16F10 and A549) in vitro. Several compounds displayed good-to-excellent potency against these cancer cell lines compared to SU5402. Structure-activity relationship analyses indicated that compounds with a rigid structure and more heteroatoms at the side chain of the parent ring were more effective than those without these substitutions. The compound N5g (37.4% FGFR1 inhibition at 1.0 mu M) was identified to have the most potent antitumor activities, with IC50 values of 5.472, 4.260 and 5.837 mu M against H460, B16F10 and A549 cell lines, respectively. Together, our results suggest that 5,7-dimethyloxazolo[ 5,4-d]pyrimidine-4,6(5H, 7H)-dione derivatives may serve as potential agents for the treatment of FGFR1-mediated cancers.